CCR4 CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCR4 CAR T cells, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) [Phase 1]